Amunine
PreclinicalEndogenous pituitary peptide
Research material. Not for human or animal consumption.
Research overview
Amunine is a name found mainly in older endocrine literature describing peptide activity on pituitary function. Direct evidence is historical: biochemical purification work and 1982 studies using pituitary cell cultures and dogs. Modern pharmacology and clinical data are not available, so the identity of any material supplied under this name needs particular care, and researchers should ask for full sequence information before planning work.
Laboratory, computational, ex vivo or animal model research is the main evidence base.
Questions about Amunine
PRODUCT QUESTIONSWhat is Amunine?
Amunine is a peptide label taken from historical pituitary physiology literature. Because modern reference data are scarce, its sequence and structure should be confirmed from the batch documentation rather than assumed from the name.
What research has been published on Amunine?
The literature consists of older work on pituitary peptide activity, including purification studies and 1982 experiments in pituitary cell cultures and dogs. No modern controlled human studies have been identified, so it is best treated as a historical research tool.
What batch documentation should accompany Amunine?
Amunine: Ask for the COA and analytical reports for the batch being quoted. Given the limited reference literature, insist on a full stated sequence, mass spectrometry that matches it, HPLC purity and the source of the reference standard used for identity testing.
How should Amunine storage conditions be assessed?
Without published stability data for Amunine, follow general peptide practice: keep it lyophilised at −20°C in a sealed, desiccated vial away from light, and verify stability before relying on stored solutions.